Surmodics reported $140.08M in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Align Technology ALGN:US $ 3516.76M 132.35M
Anika Therapeutics ANIK:US $ 290.06M 3.26M
Arrowhead Research ARWR:US $ 408.82M 28.07M
Baxter International BAX:US $ 8770M 276M
Bioscrip BIOS:US $ 1097.48M 40.87M
Cryolife CRY:US $ 311.54M 9.71M
Edap Tms EDAP:US $ 48.04M 0.15M
Edwards Lifesciences EW:US $ 5541.3M 408M
Genmark Diagnostics GNMK:US $ 94.2M 0.24M
Haemonetics HAE:US $ 698.55M 21.47M
Heron Therapeutics HRTX:US $ 118.84M 41.27M
Merit Medical Systems MMSI:US $ 1013.38M 20.94M
Mesa Laboratories MLAB:US $ 399.42M 0.41M
Nektar Therapeutics NKTR:US $ 801.54M 103.44M
Oxford Immunotec Global OXFD:US $ 191.26M 2.37M
Providence Service PRSC:US $ 403.99M 5.27M
Stryker SYK:US $ 14178M 358M
Surmodics SRDX:US $ 140.08M 0.75M
Trinity Biotech TRIB:US $ -0.5M 0.37M